Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12626 - 12650 of 14373 in total
Investigational
Investigational
A version of tabituximab barzuxetan radiolabeled with yttrium-90.
Investigational
BHT-3034 is a DNA plasmid vaccine immunotherapy under investigation for the treatment of myasthenia gravis.
Investigational
SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis Type 2 (ADO2).
Investigational
PBKR03 is a non-replicating recombinant adeno-associated virus serotype hu68 vector, containing a transgene encoding the human galactosylceramidase (GALC) enzyme.
Investigational
ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).
Investigational
Investigational
Investigational
Investigational
Investigational
LYT-200 is a fully human IgG4 monoclonal antibody directed against galectin-9.
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing metalloproteinase-1 (MMP-1).
Investigational
Investigational
Investigational
Investigational
AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.
Investigational
Investigational
Displaying drugs 12626 - 12650 of 14373 in total